Vantage Financial Partners Ltd., Inc. Abb Vie Inc. Transaction History

Vantage Financial Partners Ltd., Inc.

$394 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $198,816 - $226,532	1,244 New	1,244 $226,000
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $182,884 - $211,715	1,369 New	1,369 $204,000
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $3,615 - $4,163	-25 Reduced 1.75%	1,405 $223,000
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $46,333 - $55,566	-335 Reduced 18.98%	1,430 $231,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $57,112 - $72,608	415 Added 30.74%	1,765 $270,000
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $1.08 Million - $1.33 Million	-8,150 Reduced 85.79%	1,350 $218,000
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $74,480 - $84,546	700 Added 7.95%	9,500 $1.03 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $84,168 - $93,768	800 Added 10.0%	8,800 $991,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $28,171 - $38,034	350 Added 4.58%	8,000 $857,000
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $8,591 - $10,083	100 Added 1.32%	7,650 $670,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $80,707 - $107,998	1,100 Added 17.05%	7,550 $741,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $29,025 - $44,005	450 Added 7.5%	6,450 $491,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $108,195 - $135,375	1,500 Added 33.33%	6,000 $531,000
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $283,410 - $340,740	4,500 New	4,500 $340,000
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $368,040 - $492,840	-4,000 Closed	0 $0
Q3 2017 Nov 02, 2017	SELL	$69.85 - $89.22 $340,868 - $435,393	-4,880 Reduced 54.95%	4,000 $356,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,235 Added 1276.74%	8,880 $645,000
Q2 2017 Aug 10, 2017	BUY	N/A	645	645 $645,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners Ltd., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners Ltd., Inc. with notifications on news.

Account